Trend of Non-Alcoholic Fatty Liver Disease in Type II Diabetes Mellitus
DOI:
https://doi.org/10.36283/PJMD13-1/004Keywords:
Type II diabetes, Liver disease, NAFLD, Complications, MortalityAbstract
Background: Non-alcoholic fatty liver disease (NAFLD) is becoming quite common in Type II Diabetes Mellitus (TIIDM) as obesity and insulin resistance are common within TIIDM and it is becoming a widespread liver condition globally. This study evaluated the prevalence of NAFLD patients who also had type II diabetes.
Methods: The demographic data (name, age, body mass index (BMI), gender, occupation, duration of TIIDM, and treatment taking for TIIDM), as well as the results of the tests for these enzymes, were also recorded. Alanine transaminase (ALT) and Aspartate transaminase (AST) levels, as well as abdominal ultrasound findings of the liver, were recorded in a proforma after informed consent for a total of 200 Type II diabetic patients. Using SPSS, the data were analyzed, and stratified groups were subjected to the Chi-square tests.
Results: There was a significant difference (p<0.05) observed in NAFLD patients of TIIDM concerning age, gender, BMI, treatment, occupation, and duration of diabetes. The sample size consisted of 200 patients of which 111 (55.5%) were men and 89 (44.5%) were women. Patients ranged in the age range of 40-70 years old, with a mean age of 55.08 ± 8.98 years and a mean BMI of 29.69±4.04, respectively. It was concluded that 64% of cases with diabetes mellitus had NAFLD.
Conclusion: TIIDM is an independent risk factor for NAFLD so early screening, diagnosis, and appropriate treatment are mandatory to reduce the risk of NAFLD and its related complications.
References
Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary surgery and nutrition. 2015 Apr;4(2):101. http:// https://doi.org/10.3978%2Fj.issn.2304-3881.2015.01.03
Ahmed MH, Husain NE, Almobarak AO. Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? Journal of family medicine and primary care. 2015;4(1):45. http://doi.org/10.7759/cureus.3626
Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors, and prevention. Nature Reviews Gastroenterology & Hepatology. 2021;18(4):223-238. https://doi.org/10.1038/s41575-020-00381-6
Mandal A, Bhattarai B, Kafle P, Khalid M, Jonnadula SK, Lamicchane J, Kanth R, Gayam V, Jonnadula S. Elevated liver enzymes in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Cureus. 2018;10(11). https://doi.org/10.4103%2F2249-4863.152252
Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World journal of gastroenterology: WJG. 2008;14(22):3476. https://doi.org/10.3748%2Fwjg.14.3476
Care D. Standards of medical care in diabetes 2019. Diabetes Care. 2019;42(Suppl 1):S124-38. https://doi.org/10.2337/dc19-S008
Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH. Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2014 Nov 1;1842(11):2329-2343. https://doi.org/10.1016/j.bbadis.2014.08.004
Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Current diabetes reports. 2015;15:1-3. https://doi.org/10.1007/s11892-015-0607-4
Ijaz-ul-Haque Taseer LH, Safdar S, Mirbahar AM, Ahmad I. Frequency of nonalcoholic fatty liver disease (NAFLD) and its biochemical derangements in Type-2 diabetic patients. Pakistan Journal of Medical Sciences. 2009;25(5):817-820. DOI: 20103029404
Luxmi S, Sattar RA, Ara J. Association of non-alcoholic fatty liver with type 2 diabetes mellitus. Jlumhs. 2008;9:188-193. DOI: ID: emr-197938.
Manoria P, Inamdar S, Kumar R. Hepatobiliary dysfunction in Type-2 diabetes mellitus. Journal of Family Medicine and Primary Care. 2017;6(3):563. https://doi.org/10.4103%2F2249-4863.222018
Cho EE, Ang CZ, Quek J, Fu CE, Lim LK, Heng ZE, Tan DJ, Lim WH, Yong JN, Zeng R, Chee D. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023 Nov 1;72(11):2138-2148. http://dx.doi.org/10.1136/gutjnl-2023-330110
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003;125(2):437-443. https://doi.org/10.1016/S0016-5085(03)00907-7
Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World journal of gastroenterology: WJG. 2014;20(27):9072. https://doi.org/10.3748%2Fwjg.v20.i27.9072
Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346(16):1221-1231. DOI: 10.1056/NEJMra011775
Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096-1108. https://doi.org/10.1016/j.metabol.2016.01.001
Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Pathologic assessment of non-alcoholic fatty liver disease. Clinics in liver disease. 2007;11(1):17-23. https://doi.org/10.1016/j.cld.2007.02.002
Tomah S, Alkhouri N, Hamdy O. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? Clinical diabetes and endocrinology. 2020;6:1-1. https://doi.org/10.1186/s40842-020-00097-1
Afzal MY, Anjum HS, Siddiqui UN, Shaihd S. Nonalcoholic fatty liver disease (NAFLD) frequency in Diabetes Mellitus (DM) type–II patients. FUUAST Journal of Biology. 2016;6(1):7-10. DOI: 2222-0356
Bhatt KN, Pranav V, Dipika Y, Dharmesh N, Radhika N, Arvind S. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus and its relation with insulin resistance in South Gujarat Region. Journal of Mahatma Gandhi Institute of Medical Sciences. 2017;22(1):8-11. DOI: 10.4103/0971-9903.202001
Butt A, Hamid S, Jafri W, Salih M, Haider Z, Akhter J. Prevalence and Risk Factors of NAFLD among Native South Asian Pakistani Patients with Type 2 Diabetes and Metabolic Syndrome: 332. Official journal of the American College of Gastroenterology| ACG. 2011;106:S131. DOI: SS-332
Kanwal S, Ghaffar T, Aamir AH, Usman K. Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors. Pakistan Journal of Medical Sciences. 2021;37(5):1335. https://doi.org/10.12669%2Fpjms.37.5.4211
Singh S, Kuftinec GN, Sarkar S. Non-alcoholic fatty liver disease in South Asians: a review of the literature. Journal of clinical and translational hepatology. 2017;5(1):76. https://doi.org/10.14218%2FJCTH.2016.00045
Khademalhosseini M, Ranjbar E, Mohammadi R, Khalili P, Mehran M, Jalali N, Rajabi Z, Jamali Z. Dietary antioxidants and liver enzymes in Rafsanjan, a Region in Southeast Iran. Scientific Reports. 2023;13(1):8555. https://doi.org/10.1038/s41598-023-35385-0
Kakehashi A, Suzuki S, Wanibuchi H. Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis. Cancers. 2023;15(18):4566. https://doi.org/10.3390/cancers15184566
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
